136 related articles for article (PubMed ID: 38748373)
1. A meta-analysis of MRI radiomics-based diagnosis for BI-RADS 4 breast lesions.
Lin J; Zheng H; Jia Q; Shi J; Wang S; Wang J; Ge M
J Cancer Res Clin Oncol; 2024 May; 150(5):254. PubMed ID: 38748373
[TBL] [Abstract][Full Text] [Related]
2. High-temporal resolution DCE-MRI improves assessment of intra- and peri-breast lesions categorized as BI-RADS 4.
Liu Y; Wang S; Qu J; Tang R; Wang C; Xiao F; Pang P; Sun Z; Xu M; Li J
BMC Med Imaging; 2023 Apr; 23(1):58. PubMed ID: 37076817
[TBL] [Abstract][Full Text] [Related]
3. Predicting Breast Cancer in Breast Imaging Reporting and Data System (BI-RADS) Ultrasound Category 4 or 5 Lesions: A Nomogram Combining Radiomics and BI-RADS.
Luo WQ; Huang QX; Huang XW; Hu HT; Zeng FQ; Wang W
Sci Rep; 2019 Aug; 9(1):11921. PubMed ID: 31417138
[TBL] [Abstract][Full Text] [Related]
4. Breast DCE-MRI radiomics: a robust computer-aided system based on reproducible BI-RADS features across the influence of datasets bias and segmentation methods.
Qiao M; Li C; Suo S; Cheng F; Hua J; Xue D; Guo Y; Xu J; Wang Y
Int J Comput Assist Radiol Surg; 2020 Jun; 15(6):921-930. PubMed ID: 32388693
[TBL] [Abstract][Full Text] [Related]
5. Value of breast MRI omics features and clinical characteristics in Breast Imaging Reporting and Data System (BI-RADS) category 4 breast lesions: an analysis of radiomics-based diagnosis.
Cui Q; Sun L; Zhang Y; Zhao Z; Li S; Liu Y; Ge H; Qin D; Zhao Y
Ann Transl Med; 2021 Nov; 9(22):1677. PubMed ID: 34988186
[TBL] [Abstract][Full Text] [Related]
6. Subclassification of BI-RADS 4 Magnetic Resonance Lesions: A Systematic Review and Meta-Analysis.
Li J; Zheng H; Cai W; Wang Y; Zhang H; Liao M
J Comput Assist Tomogr; 2020; 44(6):914-920. PubMed ID: 33196599
[TBL] [Abstract][Full Text] [Related]
7. Adding a Model-free Diffusion MRI Marker to BI-RADS Assessment Improves Specificity for Diagnosing Breast Lesions.
Goto M; Le Bihan D; Yoshida M; Sakai K; Yamada K
Radiology; 2019 Jul; 292(1):84-93. PubMed ID: 31112086
[TBL] [Abstract][Full Text] [Related]
8. Role of combined clinical-radiomics model based on contrast-enhanced MRI in predicting the malignancy of breast non-mass enhancements without an additional diffusion-weighted imaging sequence.
Li Y; Yang Z; Lv W; Qin Y; Tang C; Yan X; Yin T; Ai T; Xia L
Quant Imaging Med Surg; 2023 Sep; 13(9):5974-5985. PubMed ID: 37711822
[TBL] [Abstract][Full Text] [Related]
9. Combining b2500 diffusion-weighted imaging with BI-RADS improves the specificity of breast MRI.
Saccenti L; Mellon CM; Scholer M; Jolibois Z; Stemmer A; Weiland E; de Bazelaire C
Diagn Interv Imaging; 2023 Sep; 104(9):410-418. PubMed ID: 37208291
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Performance and Accuracy of Strain Elastography for BI-RADS Category 4 Lesions among Asian Females.
Dong M; Xing B; Zhang B; Xu X; Zhou Q
J Coll Physicians Surg Pak; 2023 Oct; 33(10):1181-1187. PubMed ID: 37804027
[TBL] [Abstract][Full Text] [Related]
11. Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI.
Pan J; Tong W; Luo J; Liang J; Pan F; Zheng Y; Xie X
Br J Radiol; 2020 Aug; 93(1112):20200195. PubMed ID: 32463295
[TBL] [Abstract][Full Text] [Related]
12. The Kaiser score reliably excludes malignancy in benign contrast-enhancing lesions classified as BI-RADS 4 on breast MRI high-risk screening exams.
Milos RI; Pipan F; Kalovidouri A; Clauser P; Kapetas P; Bernathova M; Helbich TH; Baltzer PAT
Eur Radiol; 2020 Nov; 30(11):6052-6061. PubMed ID: 32504098
[TBL] [Abstract][Full Text] [Related]
13. Breast lesions classified as probably benign (BI-RADS 3) on magnetic resonance imaging: a systematic review and meta-analysis.
Spick C; Bickel H; Polanec SH; Baltzer PA
Eur Radiol; 2018 May; 28(5):1919-1928. PubMed ID: 29168006
[TBL] [Abstract][Full Text] [Related]
14. Combined contrast-enhanced magnetic resonance and diffusion-weighted imaging reading adapted to the "Breast Imaging Reporting and Data System" for multiparametric 3-T imaging of breast lesions.
Pinker K; Bickel H; Helbich TH; Gruber S; Dubsky P; Pluschnig U; Rudas M; Bago-Horvath Z; Weber M; Trattnig S; Bogner W
Eur Radiol; 2013 Jul; 23(7):1791-802. PubMed ID: 23504036
[TBL] [Abstract][Full Text] [Related]
15. Application of MRI Radiomics-Based Machine Learning Model to Improve Contralateral BI-RADS 4 Lesion Assessment.
Hao W; Gong J; Wang S; Zhu H; Zhao B; Peng W
Front Oncol; 2020; 10():531476. PubMed ID: 33194589
[TBL] [Abstract][Full Text] [Related]
16. Investigation of Synthetic Relaxometry and Diffusion Measures in the Differentiation of Benign and Malignant Breast Lesions as Compared to BI-RADS.
Gao W; Zhang S; Guo J; Wei X; Li X; Diao Y; Huang W; Yao Y; Shang A; Zhang Y; Yang Q; Chen X
J Magn Reson Imaging; 2021 Apr; 53(4):1118-1127. PubMed ID: 33179809
[TBL] [Abstract][Full Text] [Related]
17. The value of elastography strain rate ratio in benign and malignant BI-RADS-US 3-4 breast masses.
Li X; Sun W; Zhang H
Biomol Biomed; 2024 May; 24(3):625-632. PubMed ID: 38149832
[TBL] [Abstract][Full Text] [Related]
18. An MRI-Based Radiomics Model for Predicting the Benignity and Malignancy of BI-RADS 4 Breast Lesions.
Zhang R; Wei W; Li R; Li J; Zhou Z; Ma M; Zhao R; Zhao X
Front Oncol; 2021; 11():733260. PubMed ID: 35155178
[TBL] [Abstract][Full Text] [Related]
19. A simplified scoring protocol to improve diagnostic accuracy with the breast imaging reporting and data system in breast magnetic resonance imaging.
Zhong Y; Li M; Zhu J; Zhang B; Liu M; Wang Z; Wang J; Zheng Y; Cheng L; Li X
Quant Imaging Med Surg; 2022 Jul; 12(7):3860-3872. PubMed ID: 35782247
[TBL] [Abstract][Full Text] [Related]
20. Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes.
Benndorf M; Baltzer PA; Vag T; Gajda M; Runnebaum IB; Kaiser WA
Acta Radiol; 2010 Sep; 51(7):715-21. PubMed ID: 20707656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
